Phenotypic Switching of Naïve T Cells to Immune-Suppressive Treg-Like Cells by Mutant KRAS.
FOXP3
KRAS
Tregs
cell-extrinsic
lung cancer
phenotypic switching
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
18 Oct 2019
18 Oct 2019
Historique:
received:
12
09
2019
revised:
09
10
2019
accepted:
15
10
2019
entrez:
23
10
2019
pubmed:
23
10
2019
medline:
23
10
2019
Statut:
epublish
Résumé
Oncogenic (mutant) Ras protein Kirsten rat sarcoma viral oncogene homolog (KRAS) promotes uncontrolled proliferation, altered metabolism, and loss of genome integrity in a cell-intrinsic manner. Here, we demonstrate that CD4
Identifiants
pubmed: 31635338
pii: jcm8101726
doi: 10.3390/jcm8101726
pmc: PMC6832522
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA209978
Pays : United States
Organisme : NIH HHS
ID : U54CA209978
Pays : United States
Organisme : NCI NIH HHS
ID : P30CA033572
Pays : United States
Références
Oncotarget. 2016 Aug 9;7(32):51991-52002
pubmed: 27437771
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16258-63
pubmed: 22991461
Elife. 2014 Mar 12;3:e02313
pubmed: 24623306
Molecules. 2018 Apr 04;23(4):
pubmed: 29617321
Cancer Gene Ther. 2010 Feb;17(2):97-108
pubmed: 19713997
J Autoimmun. 2013 Mar;41:50-9
pubmed: 23490285
Biomed Res Int. 2018 Jan 3;2018:5473725
pubmed: 29511684
J Mol Med (Berl). 2013 Apr;91(4):411-29
pubmed: 23515621
Cell Res. 2017 Jan;27(1):109-118
pubmed: 27995907
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):12-19
pubmed: 30419312
Scand J Immunol. 2017 Dec;86(6):436-443
pubmed: 28941312
Immune Netw. 2009 Dec;9(6):209-35
pubmed: 20157609
J Cell Biochem Suppl. 2001;Suppl 36:1-11
pubmed: 11455565
Int Immunol. 2009 Oct;21(10):1105-11
pubmed: 19737784
J Exp Clin Cancer Res. 2017 Aug 30;36(1):113
pubmed: 28854931
Appl Microbiol Biotechnol. 2011 Dec;92(6):1251-60
pubmed: 21667275
Cell Metab. 2017 Jun 6;25(6):1282-1293.e7
pubmed: 28416194
Sci Rep. 2016 Nov 15;6:37012
pubmed: 27845397
Front Immunol. 2018 May 08;9:871
pubmed: 29867925
Ann Oncol. 2016 Aug;27(8):1482-92
pubmed: 27069014
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
FEBS J. 2016 Jul;283(14):2731-48
pubmed: 26787424
Cell Mol Life Sci. 2017 Sep;74(17):3245-3261
pubmed: 28597297
Genome Med. 2018 Mar 26;10(1):23
pubmed: 29580275
Trends Immunol. 2013 Jan;34(1):33-40
pubmed: 22999714
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9066-E9075
pubmed: 29073103
Oncogenesis. 2018 May 25;7(5):41
pubmed: 29799520
Genes Cancer. 2011 Feb;2(2):166-72
pubmed: 21779490
Appl Microbiol Biotechnol. 2011 May;90(4):1381-8
pubmed: 21360146
Int Immunol. 2016 Aug;28(8):401-9
pubmed: 27160722
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
PLoS One. 2010 Jan 14;5(1):e8703
pubmed: 20090846
Plasmid. 2007 May;57(3):286-95
pubmed: 17207855
J Clin Invest. 2006 Sep;116(9):2434-41
pubmed: 16906223
Mol Cancer. 2018 Feb 19;17(1):33
pubmed: 29455666
Elife. 2019 May 28;8:
pubmed: 31134894
Blood. 2012 May 10;119(19):4430-40
pubmed: 22438251
J Am Chem Soc. 2016 Oct 12;138(40):13187-13196
pubmed: 27665622
Gastroenterology. 2012 Jul;143(1):145-54
pubmed: 22475534
Cancer Immunol Res. 2016 Apr;4(4):354-65
pubmed: 26880715
Front Mol Biosci. 2017 Jul 18;4:50
pubmed: 28770210